Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026)

Analysis

Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -417.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 216.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 110.21 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 593.21 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 347.92 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 161.89 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 247.47 Mn
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn - 10.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.99 Mn
Mar 31, 2026 9.47 Mn
Dec 31, 2025 14.03 Mn
Sep 30, 2025 10.40 Mn
Jun 30, 2025 10.34 Mn
Mar 31, 2025 11.32 Mn
Dec 31, 2024 12.38 Mn
Sep 30, 2024 13.28 Mn
Jun 30, 2024 12.32 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 12.51 Mn
Sep 30, 2023 13.38 Mn
Jun 30, 2023 13.23 Mn
Mar 31, 2023 13.76 Mn
Dec 31, 2022 11.86 Mn
Sep 30, 2022 12.49 Mn
Jun 30, 2022 10.99 Mn
Mar 31, 2022 10.73 Mn
Dec 31, 2021 10.81 Mn
Sep 30, 2021 10.86 Mn